Controlling the chemical stability of a moisture-sensitive drug product through monitoring and identification of coating process microenvironment.

The objective of this work was to monitor and identify the impact of coating microenvironment, as measured by PyroButtons(®) data loggers, on the chemical stability of a moisture-sensitive drug molecule brivanib alaninate (BA). BA tablets were coated at two different scales (15 and 24 in pan). PyroButtons(®) data loggers were allowed to move freely within the tablet bed to record the temperature and relative humidity conditions of the tablet bed. The tablet moisture content at the end of the coating runs, and the rate of hydrolysis of the BA tablets based on HPLC analysis was found to be a function of the coating thermodynamic microenvironment. Wetter coating conditions resulted in tablets with higher water content and showed greater degradation upon storage. The coating process which yielded acceptable stability in a 15 in coater was transferred to a 24 in coater by maintaining similar tablet-bed relative humidity and temperature conditions. This was compared to a traditional scale-up approach where the environmental equivalency factor (EEF) was matched between scales during coating. The moisture content observed across the two scales indicated that maintaining a similar tablet-bed microenvironment ensured consistent results between scales.

[1]  Linda A. Felton,et al.  Influence of Process Parameters on Tablet Bed Microenvironmental Factors During Pan Coating , 2013, AAPS PharmSciTech.

[2]  J. Yliruusi,et al.  Influence of the Aqueous Film Coating Process on the Properties and Stability of Tablets Containing a Moisture‐Labile Drug , 2003, Pharmaceutical development and technology.

[3]  Amit Mehrotra,et al.  Use of Commercial Data Loggers to Develop Process Understanding in Pharmaceutical Unit Operations , 2010, Journal of Pharmaceutical Innovation.

[4]  Preetanshu Pandey,et al.  Understanding the thermodynamic micro-environment inside a pan coater using a data logging device , 2014, Drug development and industrial pharmacy.

[5]  Ganeshkumar A. Subramanian,et al.  Mechanistic basis for the effects of process parameters on quality attributes in high shear wet granulation. , 2012, International journal of pharmaceutics.

[6]  G. Peck,et al.  The Swelling of Core Tablets During Aqueous Coating I: A Simple Model Describing Extent of Swelling and Water Penetration for Insoluble Tablets Containing a Superdisintegrant , 1991 .

[7]  J. Siepmann,et al.  Protection of moisture-sensitive drugs with aqueous polymer coatings: importance of coating and curing conditions. , 2009, International journal of pharmaceutics.

[8]  Preetanshu Pandey,et al.  Real-time monitoring of thermodynamic microenvironment in a pan coater. , 2013, Journal of pharmaceutical sciences.

[9]  S. Badawy,et al.  Acid-catalyzed hydrolysis of BMS-582664: degradation product identification and mechanism elucidation. , 2012, Journal of pharmaceutical sciences.

[10]  John C. Strong Psychrometric Analysis of the Environmental Equivalency Factor for Aqueous Tablet Coating , 2009, AAPS PharmSciTech.

[11]  Brian M. Zacour,et al.  Correlating bilayer tablet delamination tendencies to micro-environmental thermodynamic conditions during pan coating , 2014, Drug development and industrial pharmacy.

[12]  Garnet E. Peck,et al.  The Effect of Swelling Characteristics of Superdisintegrants on the Aqueous Coating Solution Penetration into the Tablet Matrix During the Film Coating Process , 2004, Pharmaceutical Research.

[13]  Ganeshkumar A. Subramanian,et al.  Quality by design development of brivanib alaninate tablets: degradant and moisture control strategy. , 2014, International journal of pharmaceutics.

[14]  Richard Turton,et al.  Scale-up of a pan-coating process , 2008, AAPS PharmSciTech.

[15]  P. Pollock,et al.  Brivanib Alaninate, a Dual Inhibitor of Vascular Endothelial Growth Factor Receptor and Fibroblast Growth Factor Receptor Tyrosine Kinases, Induces Growth Inhibition in Mouse Models of Human Hepatocellular Carcinoma , 2008, Clinical Cancer Research.